Patient Advocacy Grant is sponsored by American Society for Reproductive Medicine (ASRM). This initiative provides grants for US-based organizations to support existing or new federal, state, and local reproductive health advocacy initiatives, educational programs, and/or patient-related events.

ASRM Patient Advocacy Grant | American Society for Reproductive Medicine | ASRM ASRM Patient Advocacy Grant Program Congratulations to the Newest Grant Recipients!

Download the ASRM Patient Advocacy Grant Program Checklist The purpose of the ASRM Patient Advocacy Grants Program is to award funds to patient advocacy organizations to support advocacy efforts and educational programs for patients and communities impacted by reproductive health issues.

In fiscal year 2025, ASRM will award up to $150,000 to be distributed among multiple awardees, at a maximum of $50,000 each, through a competitive grant process. The applicant program period should be for no more than 1-year. Grant proposal submissions will be accepted beginning May 17, 2024 with a deadline of July 19, 2024 @ 4pm EST .

Award notifications and funding disbursements will be made in late summer/fall 2024. Applicant organizations must be based in the United States or its territories. Submissions from teams that include both U.S. and international members are eligible, with the lead applicant based in the US.

Only applicant nonprofit organizations that are considered tax exempt under Section 501(c) of the Internal Revenue Code and are not private foundations will be considered. For questions related to eligibility please contact research@asrm. org .

ASRM may require additional documentation. The American Society for Reproductive Medicine invites application submissions for the Patient Advocacy Initiative. The purpose of this initiative is to provide grants for US based organizations to support existing or new federal, state, and local reproductive health advocacy initiatives, educational programs, and/or patient-related events (e.g., support group activities).

Grants with a programmatic focus on inclusivity of patient groups, diverse advocacy issues and access to care are highly recommended. An application must include the following information in order as described below. Additionally, all letters must be included in your application package and cannot be sent separately or post application deadline.

Please note: Letters of support are not required but can be used to support the need for funding.

An application must include: Title of the project (not to exceed 200 characters including spaces) Organization’s name Organization’s contact person and contact information (email, phone, address) Total funding amount requested Letters of support (optional, 2 max) A LOS can be included to provide outside testimonial that backs up a nonprofit's claims of success and promises to deliver, or to provide additional information regarding gaps and needs.

Evidence that the organization is a non-profit, tax exempt 501(c) charitable organization in good standing Written confirmation of tax-exempt status (W-9 or IRS letter) Abstract (One page maximum) Lay-person Abstract (500 words) describing the project in general terms Program Description (no more than three pages) Significance and potential impact to stakeholders in the reproductive health field Timeline for project start up, implementation, and completion A detailed budget and budget justification for the program proposed Funds are available for advocacy, educational, and project expenses, technical assistance, programmatic supplies, etc. Funds may not be used towards day-to-day operational expenses The proposal must be typed in Calibri 12 pt.

type with page margins no less than . 5 inches and no more than 1 inch. Pagination should be included at the bottom of each page (excluding the Title page).

The entire application (including completed checklist) must be submitted as ONE PDF FILE to research@asrm. org by 4pm EST on July 19, 2024 . ASRM will review the proposals and awardees determined (The review committee will be identified through standard ASRM process).

To avoid a potential conflict of interest, individuals with close affiliations with an applicant will be recused from reviewing that application. A final project progress report is required and due within 60 days of the project period end. The report should be submitted to research@asrm.

org . ASRM will review and provide a confirmation of the progress report acceptance via email. A no-cost extension may be requested/considered, 30-days prior to the end of the proposed program period, for an additional year.

This request must be in submitted to ASRM in writing by emailing research@asrm. org . Additional information may be required for consideration and approval.

Further information about this process can be provided by emailing research@asrm. org . ASRM's Office of Public Affairs coordinates advocacy efforts to promote policies that support reproductive health and rights.

View ASRM's Advocacy Activities ASRM has prepared a collection of talking points to help you advocate for reproductive healthcare. View the Advocacy Resources Take Action To Protect Reproductive Medicine! Learn to advocate on the federal state and local level.

The importance of your involvement in the lobbying process, especially at the local level, has never been greater. The ASRM Center For Policy And Leadership The ASRM Center for Policy and Leadership (CPL), established in 2020, builds on ASRM’s longstanding role as a leading policy voice on Capitol Hill and in state capitals. Donate to the Advocacy in Action Fund Fight legislation that will impede patient care.

View more on the topic of access to care ASRM Responds to Supreme Court Mifepristone Decision ASRM supports continued access to mifepristone, warning that unnecessary restrictions could delay reproductive healthcare and harm patients.

Journal Club Global (Portuguese): Access to fertility services by transgender and nonbinary persons ASRM webinar explores transgender and non-binary fertility care, preservation options, gender dysphoria, ethics, and inclusive reproductive healthcare.

ASRM Responds to Trump Administration’s Announcement Regarding Insurance for Fertility Care ASRM responds to Trump IVF insurance proposal, urging broader fertility care access and public input on draft coverage rules.

New Research Examines Range of Restorative Reproductive Medicine Practices from Evidence-Based Perspective ASRM’s Fertility and Sterility series examines restorative reproductive medicine, IVF alternatives, and evidence-based fertility care amid growing policy debate.

ASRM Center for Policy and Leadership Warns Federal Funding Cuts Are Undermining Reproductive Health Infrastructure Federal funding cuts to NIH, CDC, and FDA threaten reproductive health research, patient safety, and access to care, warns new ASRM policy report. The U.S. Federal Government and Reproductive Health The Impact of Federal Funding Cuts on Patients, Providers, and the Field of Reproductive Medicine.

View the Advocacy Resource Group Spotlight: Access to Care SIG Access to Care SIG brings together clinicians, researchers, advocates, and industry partners to rethink how care is delivered. Learn more about ATC group.

American Society for Reproductive Medicine Responds to TrumpRx Announcement, Says IVF Access Requires More Than Lower Drug Prices ASRM has responded to the latest announcement about TrumpRx and its impact on IVF treatments.

ASRM Responds to Speaker Johnson’s Stripping of Fertility Coverage for America’s Military Personnel ASRM condemns Speaker Johnson’s removal of TRICARE fertility coverage from NDAA, urging action to restore IVF benefits for U.S. military families. ASRM INNOVATE spotlighted the energy of innovation in reproductive medicine and how collaboration will shape the future of fertility and reproductive health.

Improving access to care and delivery to marginalized and vulnerable populations: a committee opinion (2025) ASRM committee opinion on reducing infertility care disparities, outlining barriers and actionable strategies to improve equitable access.

Key Abstracts Presented at the ASRM 2025 Scientific Congress & Expo ASRM 2025 reveals support for IVF access, wildfire smoke's fertility risks, and how insurance mandates improve outcomes in reproductive health care.

American Society for Reproductive Medicine Reacts to White House Announcement on IVF Coverage ASRM applauds the White House’s first steps toward IVF access but underscores that true equity demands mandatory insurance coverage. ASRM Decries Latest Cuts at CDC ASRM condemns sweeping staff cuts at CDC and HHS, warning they threaten reproductive and public health.

Preparing Experts in Reproductive Medicine to Engage Decisionmakers ASRM’s PRIMED program trains reproductive health experts to advocate for evidence-based policy, empowering professionals to engage lawmakers and advance care access.

ASRM PRIMED Program continues mission View the Latest Tech Talk post Assisted Reproductive Technology (ART) Oversight: Lessons for the United States from Abroad A comprehensive analysis of global Assisted Reproductive Technology (ART) regulations, comparing policies, accessibility, and ethical considerations in various countries.

View the advocacy resource ASRM Announces FY25 Patient Advocacy Grant Awardees Congratulations to the Newest Grant Recipients! View more information about the patient advocacy grant ASRM's "Opposition Rebuttal" fact sheet counters common arguments against assisted reproductive technologies, offering evidence-based support for ART practices.

What support for IVF looks like Bipartisan support for IVF, that is responsible for the birth of over 2% of all babies born in the USA each year, will ensure that families continue to grow.

View the advocacy resource Why IVF patients often need multiple embryos to have a baby View the advocacy resource Oversight of IVF in the US In the US, medical care is regulated by a complex and comprehensive network of federal and state regulations and professional oversight.

View the advocacy resource Ethical considerations for telemedical delivery of fertility care: an Ethics Committee opinion (2024) Telemedicine has the potential to increase access to and decrease the cost of care.

View the Committee Opinion Cross-border reproductive care: an Ethics Committee opinion (2022) Cross-border reproductive care is a growing worldwide phenomenon, raising questions about why assisted reproductive technology patients travel for care.

View the Ethics Committee Document Reproductive and infertility care in times of public health crises: an Ethics Committee opinion (2022) Public health crises often require a framework shift in which patient autonomy is balanced with the need to safeguard the health of the community.

View the Committee opinion Access to fertility treatment irrespective of marital status, sexual orientation, or gender identity: an Ethics Committee opinion (2021) Individuals and couples should have access to fertility services irrespective of marital status, sexual orientation, or gender identity.

View the Committee Opinion Disparities in access to effective treatment for infertility in the United States: an Ethics Committee opinion (2021) In the United States, economic, racial, ethnic, geographic, and other disparities prevent access to fertility treatment and affect treatment outcomes.

View the Committee Opinion Exploring Access to Care for Marginalized Communities Course Enhance your skills and contribute to reducing healthcare disparities for marginalized communities.

Learn more about the Exploring Access to Care for Marginalized Communities Course Access to Care Special Interest Group (ATCSIG) The Access To Care Special Interest Group's purpose is to foster the growth of knowledge among the ASRM membership and the medical community regarding the unmet needs that exist today in access to reproductive care Learn more about the Special Interest Group View all Access to Care resources View more on the topic of advocacy May 2026: Advocacy in Action A summary of federal and state legislation, and highlighting advocacy and outreach efforts of our members.

See what Advocacy Activities ASRM is up to 2026 Advocacy Activities Report View the letters, amicus briefs, and sign-ons that ASRM has submitted to protect reproductive care. ASRM Center for Policy and Leadership Warns Federal Funding Cuts Are Undermining Reproductive Health Infrastructure Federal funding cuts to NIH, CDC, and FDA threaten reproductive health research, patient safety, and access to care, warns new ASRM policy report.

National Infertility Awareness Week April 18-24, 2027, is National Infertility Awareness Week (NIAW)! March 2026: Advocacy in Action A summary of federal and state legislation, and highlighting advocacy and outreach efforts of our members. See what Advocacy Activities ASRM is up to April 2026: Advocacy in Action A summary of federal and state legislation, and highlighting advocacy and outreach efforts of our members.

See what Advocacy Activities ASRM is up to February 2026: Advocacy in Action A summary of federal and state legislation, and highlighting advocacy and outreach efforts of our members. See what Advocacy Activities ASRM is up to 2025 Wrapped: Advocacy and Engagement in the Office of Public Affairs Explore ASRM’s 2025 advocacy wins, IVF policy updates, federal funding fights, and state mandates shaping reproductive medicine access.

View the ASRM Advocacy Wins From Guidance to Global Impact: How ASRM’s Updated Definition of Infertility Helped Shape Policy in Australia SRM's updated infertility definition became a catalyst for regulatory action internationally and yielded new hope for growing families on the other side of the world.

ASRM Launches New Ambassador Program to Strengthen Volunteer Engagement ASRM has announced the official launch of the ASRM Ambassador Program, previously unveiled during the 2025 Scientific Congress. ASRM Ambassador Program Launches January 2026: Advocacy in Action A summary of federal and state legislation, and highlighting advocacy and outreach efforts of our members.

See what Advocacy Activities ASRM is up to December 2025: Advocacy in Action A summary of federal and state legislation, and highlighting advocacy and outreach efforts of our members. See what Advocacy Activities ASRM is up to November 2025: Advocacy in Action A summary of federal and state legislation, and highlighting advocacy and outreach efforts of our members.

See what Advocacy Activities ASRM is up to Fertility and Sterility Publishes Editorial Exploring the Origins of “Restorative Reproductive Medicine” and Why Modern Fertility Care Must Remain Comprehensive Restorative reproductive medicine overlooks IVF, male-factor care, and the need for full-spectrum fertility treatment using modern technologies.

American Society for Reproductive Medicine Reacts to White House Announcement on IVF Coverage ASRM applauds the White House’s first steps toward IVF access but underscores that true equity demands mandatory insurance coverage. ASRM Today: Advocacy and Activism A behind‑the‑scenes look at how ASRM mobilizes the medical community—members, stories, advocacy—to shape reproductive rights and justice.

ASRM Decries Latest Cuts at CDC ASRM condemns sweeping staff cuts at CDC and HHS, warning they threaten reproductive and public health. 2025 Advocacy Activities Report View the letters, amicus briefs, and sign-ons that ASRM has submitted to protect reproductive care.

Empathy in Action: Strengthening the Patient-Provider Connection Dr. Tara Harding discusses how healthcare providers can foster empathy, trust, and patient-centered care to improve women's health outcomes. View the ASRMed Talk Video Are you an ASRM member looking to sharpen your advocacy skills? The Office of Public Affairs has an exciting opportunity for you!

2024 Advocacy Activities Report View the letters, amicus briefs, and sign-ons that ASRM has submitted to protect reproductive care. ASRM Announces FY25 Patient Advocacy Grant Awardees Congratulations to the Newest Grant Recipients!

View more information about the patient advocacy grant What support for IVF looks like Bipartisan support for IVF, that is responsible for the birth of over 2% of all babies born in the USA each year, will ensure that families continue to grow.

View the advocacy resource Why IVF patients often need multiple embryos to have a baby View the advocacy resource Oversight of IVF in the US In the US, medical care is regulated by a complex and comprehensive network of federal and state regulations and professional oversight. View the advocacy resource 2023 Advocacy Activities Report View the letters, amicus briefs, and sign-ons that ASRM has submitted to protect reproductive care.

The ASRM Patient Advocacy Grants Program awards funds to patient advocacy organizations to support advocacy efforts and educational programs for patients. View more information about the patient advocacy grant View all Advocacy resources